Life Sciences – Fortune 500 Pharma

Acceleration Strategies


Designed and led the launch of an industry-leading Compassionate Use (Expanded Access) program never created before to accelerate desperately needed solutions to terminally ill patients.


Integrated new processes into existing operations, creating cross-functional alignment to support this critical lifesaving initiative setting a precedent in history.  The net result was that thousands of lives were helped prior to the official releases of the drug.